Harbour BioMed Announces Submission of IND Application for HBM9378/SKB378 in the Treatment of Chronic Obstructive Pulmonary Disease November 8, 2024 β 17:45
Live from ESMO 2024 | Ascentage Pharma Releases Latest Data Showing Sustained Clinical Efficacy of Olverembatinib in SDH-Deficient GIST during a Mini Oral Presentation September 14, 2024 β 08:18
Transcenta Holding Limited (Stock Code: 6628.HK) Announce 2024 Interim Results August 29, 2024 β 14:31
ACROBiosystems Launches GMP Brand Resilient Supply at ISSCR to Accelerate Cell and Gene Therapy Development July 19, 2024 β 00:00
Daqo New Energy’s Subsidiary Xinjiang Daqo Provides Latest Update on its Litigation Event July 17, 2024 β 22:49
Flourishing port development reveals China’s reform and opening up in new era July 17, 2024 β 10:56